iXLife Capital
Overview
iXLife Capital is a venture capital firm based in France that specializes in early-stage biotechnology and life sciences investments, focusing on innovative therapies for oncology, neurology, and rare diseases.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Pharmaleads | Oct 2014 | VC Round | Co-investor |
| ATANIS Biotech AG | Mar 2023 | Early Funding | Lead |
| SeaBeLife | Oct 2025 | Early Funding | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is iXLife Capital based?
iXLife Capital is headquartered in Marly-le-Roi, France.
When was iXLife Capital founded?
iXLife Capital was founded in 2010.
How many portfolio companies does iXLife Capital have?
iXLife Capital has 3 portfolio companies in Caplight's dataset.
What are some companies in iXLife Capital's portfolio?
Portfolio companies visible on Caplight include Pharmaleads, ATANIS Biotech AG, SeaBeLife.
What was iXLife Capital's most recent investment shown here?
iXLife Capital's most recent investment in this portfolio sample was in SeaBeLife in 2025.
What sectors does iXLife Capital focus on?
iXLife Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does iXLife Capital focus on?
Stage focus information for iXLife Capital is not publicly available.